Role of mucosal ablative therapy in the treatment of the columnar-lined esophagus

Chest Surgery Clinics of North America

Volumn 12, Issue 1, 2002, Pages 185-203

  Pacifico, Rodney J ^a   Wang, Kenneth K ^a,b  

^a MAYO CLINIC   (United States)

^b ST MARY S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOTOSENSITIZING AGENT;

ARGON PLASMA COAGULATION; BARRETT ESOPHAGUS; CANCER CONTROL; CANCER INHIBITION; CANCER RISK; CLINICAL TRIAL; DYSPHAGIA; ELECTROCOAGULATION; ENDOSCOPIC MUCOSAL ABLATION; FEVER; HUMAN; LASER SURGERY; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; STOMACH ACID SECRETION; SURGICAL TECHNIQUE; THORAX PAIN; TREATMENT INDICATION; TREATMENT OUTCOME; YAG LASER;

EID: 0036187937     PISSN: 10523359     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1052-3359(03)00073-5     Document Type: Review

References (92)

1. Photodynamic therapy for dysplastic Barrett's oesophagus: A prospective, double blind, randomised, placebo controlled trial
2. High-grade dysplasia in the columnar lined esophagus
3. Bicap cautery converts Barrett's epithelium to squamous
4. Barrett's oesophagus: Effect of antireflux surgery on symptom control and development of complications
5. Photothermal laser ablation of Barrett's oesophagus: Endoscopic and histological evidence of squamous re-epithelialisation
6. Barrett's esophagus: Treatment with 5-animolevulinic acid photodynamic therapy
7. Eradication of high-grade dysplasia in columnarlined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX
8. Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium
9. The histopathology of treated Barrett's esophagus: Squamous reepithelialization after acid suppression and laser and photodynamic therapy
10. Distribution of cytokeratin markers in Barrett's specialized columnar epithelium
11. Regression of columnar esophageal (Barrett's) epithelium after anti-reflux surgery
12. Repeat laser therapy of recurrent Barrett's epithelium: Success with anacidity
13. Laser-induced transient regression of Barrett's epithelium
14. Proceedings from an international conference on ablation therapy for Barrett's mucosa
15. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma
16. Restoration of the normal squamous lining in Barrett's esophagus by argon beam plasma coagulation
17. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: A pathological study
18. Gastric acid hypersecretion in refractory gastroesophageal reflux disease
19. Treatment of Barrett's esophagus with H2 blockers
20. Continuous treatment with omeprazole 20 mg daily for up to 6 years in Barrett's oesophagus
21. A new physiologic approach for the surgical treatment of patients with Barrett's esophagus
22. Long term results of classic antireflux surgery in 152 patients with Barrett's esophagus: Clinical, radiologic, endoscopic, manometric, and acid reflux test analysis before and late after operation
23. Surgical therapy in Barrett's esophagus
24. Treatment of Barrett's esophagus by endoscopic argon plasma coagulation
25. The rational for esophagectomy as the optimal therapy with high-grade dysplasia
26. Endoscopic mucosal resection of early cancer and highgrade dysplasia in Barrett's esophagus
27. Unresolved issues in Barrett's esophagus in the new millennium
28. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia
29. Resection for Barrett's mucosa with high-grade dysplasia: Implications for prophylactic photodynamic therapy
30. Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy
31. KTP laser destruction of dysplasia and early cancer columnar-lined Barrett's esophagus
32. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid
33. The efficacy and safety of argon plasma coagulation therapy in Barrett's esophagus
34. Argon plasma coagulation (APC): Ballyhoo or breakthrough?
35. Endoscopic argon plasma coagulation (APC): First clinical experiences in flexible endoscopy
36. Multipolar electrocoagulation in the treatment of Barrett's esophagus
37. Regression of Barrett's esophagus: The role of acid suppression, surgery and ablative methods
38. Barrett's esophagus: Development of dysplasia and adenocarcinoma
39. The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus
40. Development of adenocarcinoma in Barrett's oesophagus after successful antireflux surgery
41. Barrett's esophagus with high-grade dysplasia: An indication for prophylactic esophagectomy
42. Effects of long-term medical treatment with cimetidine and bethanechol in patients with esophagitis and Barrett's esophagus
43. Length of Barrett's oesophagus: An important factor in the development of dysplasia and adenocarcinoma
44. Long-term treatment with omeprazole for refractory reflux esophagitis: Efficacy and safety
45. Barrett's ulcer and treatment with cimetidine
46. Successful reversal of Barrett's esophagus with multipolar electrocoagulation despite inadequate acid suppression
47. Biomarkers in Barrett esophagus
48. Initial results using low-dose photodynamic therapy in the treatment of Barrett's esophagus
49. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus
50. Natural history of high-grade dysplasia in Barrett's esophagus
51. Failure of Nd:YAG photocoagulation therapy as treatment for Barrett's oesophagus - A pilot study
52. Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole
53. Barrett's esophagus in patients with symptomatic reflux esophagitis
54. Local therapy of early cancer in short Barrett's esophagus by means of argon plasma coagulation: Initial experience
55. Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus
56. Antireflux surgery followed by bipolar electrocoagulation in the treatment of Barrett's esophagus
57. Barrett's esophagus: Update on screening, surveillance, and treatment
58. Reconstitution of squamous epithelium in Barrett's oesophagus with endoscopic argon plasma coagulation: A prospective study
59. Long term continuous omeprazole treatment of patients with Barrett's oesophagus
60. Occult esophageal adenocarcinoma: Extent of disease and implication for effective therapy
61. Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett's esophagus
62. Conservative treatment versus antireflux surgery in Barrett's oesophagus
63. Photodynamic therapy in the management of Barrett's esophagus with dysplasia
64. Photodynamic therapy for Barrett's esophagus: Follow-up in 100 patients
65. Results of photodynamic therapy for ablation of dysplasia and early cancer in Barrett's esophagus and effect of oral steroids on stricture formation
66. Barrett's esophagus with high-grade dysplasia: An indication for esophagectomy?
67. High power setting argon plasma coagulation for the eradication of Barrett's esophagus
68. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and non-surveyed patients
69. A guide for surveillance of patients with Barrett's esophagus
70. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: Prospective endoscopic surveillance of a cohort
71. Surgical management of high-grade dysplasia in Barrett's esophagus
72. Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus
73. Regression and progression of Barrett's oesophagus after antireflux surgery
74. Treatment of Barrett's esophagus by endoscopic laser ablation and antireflux surgery
75. Effect up to 3 years of high-dose lansoprazole on Barrett's esophagus
76. Partial regression of Barrett's esophagus: An inadequate endpoint
77. Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: Preliminary results
78. Lack of impact of therapy on extent of Barrett's esophagus in 67 patients
79. Regression of Barrett's esophagus by laser ablation in an anacid environment
80. High-grade dysplasia (HGD) is not an indication for surgery in patients (Pts) with Barrett's esophagus (BE)
81. Ablation of Barrett's epithelium by endoscopic argon plasma coagulation in combination with high-dose omeprazole
82. Durability of new squamous epithelium after endoscopic reversal of Barrett's esophagus
83. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus
84. Combination of endoscopic argon plasma coagulation and antireflux surgery for treatment of Barrett's esophagus
85. Endoscopic ablation therapy for Barrett's esophagus with high-grade dysplasia: A review
86. Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: Immediate and mid term results
87. Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus
88. Current status of photodynamic therapy of Barrett's esophagus
89. Photodynamic therapy of Barrett's esophagus
90. Effect of long-term treatment with cimetidine and antacids in Barrett's oesophagus
91. Effect of antireflux operation on Barrett's mucosa
92. High-grade dysplasia in Barrett's oesophagus - How should it be managed?